On March 11, 2026, Dogwood Therapeutics, Inc. held a Special Meeting where shareholders approved all matters voted upon, including the exercise of a warrant for 4,386,037 shares. This meeting constituted a quorum with 88.03% of voting power present.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.